The present study aims to evaluate the prognostic significance of LDH and dNLR in patients with advanced HER2 positive breast cancer treated with T-DM1, and investigate whether LDH and dNLR was able to predict treatment response to T-DM1. The gene discussed is ERBB2; the disease is breast cancer.